Total Funding
59
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1109519
Medisyn Technologies develops pre-qualified proprietary drug compounds for breast, renal, prostate, and lung cancer treatments.
About the Company
Medisyn Technologies, Inc., a biotechnology company, develops pre-qualified proprietary drug compounds. Its Forward Engineering platform is used for producing compounds for breast, renal, prostate, and lung-cancer treatments. The company also analyzes and optimizes existing drugs, and develops new drug candidates for its partners. In addition, it
offers testing and analysis services to predict safety and efficacy of compounds. The company serves biotech and pharmaceutical companies. Medisyn Technologies, Inc. was founded in 1999 and is headquartered in Minnetonka, Minnesota.
